Strong Financial Performance and Strategic Advancements by MEDICLIN Aktiengesellschaft and Soligenix Inc.
Update: 2025-11-04
Description
MEDICLIN Aktiengesellschaft reports a significant increase in group operating result and sales, with steady capacity utilization. Soligenix Inc. has bolstered its financial standing through a public offering, ensuring funding for key clinical and regulatory milestones, highlighting its commitment to advancing late-stage therapeutics and vaccine candidates.
Comments
In Channel



